Showing posts with label Drugs of Abuse Testing Market. Show all posts
Showing posts with label Drugs of Abuse Testing Market. Show all posts

Monday, 28 August 2017

Drugs of Abuse Testing Market is Anticipated to Show the Robust Growth During 2016 - 2024

The top seven players in the global drugs of abuse testing market accounted for 63.7% in the market in 2015. The leading players Alere, Inc., F. Hoffmann La-Roche Ltd., Siemens Healthineers (Siemens AG), Thermo Fisher Scientific, Inc., Drägerwerk AG & Co. KGaA, Shimadzu Corporation, and Laboratory Corporation of America Holdings. Of these, Alere Inc. held a dominant share in the global market with its wide product portfolio for drugs of abuse testing, observes Transparency Market Research. “Companies are focused on ensuring organic and inorganic growth through acquisitions and development of new products,” states the lead author of this study.

According to the research report, the global drugs of abuse testing market is estimated to be worth US$6.4 bn by the end of 2024 as compared to US$4.1 bn in 2015. Between the forecast years of 2016 and 2024, the global market is expected to surge at a CAGR of 5.3%.

This 172 page report gives readers a comprehensive overview of the drugs of abuse testing market. Browse through 30 data tables and 83 figures to unlock the hidden opportunities in this market: http://www.transparencymarketresearch.com/drugs-abuse-testing-market.html

North America Shows Continued Growth in Global Drugs of Abuse Testing Market

In terms of geography, North America is projected to lead the global market as it estimated to rise at a CAGR of 5.7%. The growth of the North America drugs of abuse testing market will be attributable to the ever-growing demand for testing and screening all across the U.S. High level of awareness and efforts to ensure an efficient and safe working place is expected to keep the demand for these screening across the U.S. steady during the forecast period. Out of the various end users, the diagnostic laboratories are projected to lead with a CAGR of 5.3% between 2016 and 2024.

High Prevalence of Drug Abuse Augurs Well for Overall Market

The unfortunate and illicit consumption of drugs across the world has been the primary growth driver for the global drugs of abuse testing market. Rising incidences of substance abuse and its negative impact on the lives of abusers as well as those around them have forced governments and several non-profit organizations to take a stern stand against these harmful activities. Owing to this very reason, several hospitals, offices, diagnostic laboratories, and forensic laboratories are adopting various ways of testing for drug abuse. On-the-spot testing is also gaining traction in order to ensure random checks to reduce the incidence of mishaps due to abuse.

Presence of several clinical laboratories across the globe is yet another reason fueling the demand for drugs of abuse testing products. Growing number of hospitals that depend on laboratories are expected to boost the demand for products such as sample collection devices and analyzers. Furthermore, stringent norms at workplaces to ensure employees are not involved in drugs is expected to augment the demand for work place screening in the coming years. The skyrocketing number of deaths due to rising incidence of abuse of prescription drugs is estimated to drive the market as well.

Request a sample of this report to know what opportunities will emerge in the rapidly evolving drugs of abuse testing market during 2016 - 2024: http://www.transparencymarketresearch.com/drugs-abuse-testing-market.html

Low Rate of Awareness in Developing Economies to Hamper Market

Though the global market has robust growth drivers, it is being tugged in the opposite direction by the lowering reimbursement rates. Poor reimbursement policies are likely to have a negative impact on the growth of the global drugs of abuse testing market. The market is also being restrained by the low rate of awareness in emerging economies of Asia Pacific, Latin America, and Africa. The high poverty and rampant abuse of drugs in these regions is anticipated to act as an impediment for overall market during the forecast period.

This review is based on Transparency Market Research’s research report, titled “Drugs of Abuse Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024.”

Monday, 22 May 2017

Drugs of Abuse Testing Market 2016 - Industry Perspective and Comprehensive Analysis 2024

The top seven players in the global drugs of abuse testing market accounted for 63.7% in the market in 2015. The leading players Alere, Inc., F. Hoffmann La-Roche Ltd., Siemens Healthineers (Siemens AG), Thermo Fisher Scientific, Inc., Drägerwerk AG & Co. KGaA, Shimadzu Corporation, and Laboratory Corporation of America Holdings. Of these, Alere Inc. held a dominant share in the global market with its wide product portfolio for drugs of abuse testing, observes Transparency Market Research. “Companies are focused on ensuring organic and inorganic growth through acquisitions and development of new products,” states the lead author of this study.
According to the research report, the global drugs of abuse testing market is estimated to be worth US$6.4 bn by the end of 2024 as compared to US$4.1 bn in 2015. Between the forecast years of 2016 and 2024, the global market is expected to surge at a CAGR of 5.3%.
This 172 page report gives readers a comprehensive overview of the drugs of abuse testing market. Browse through 30 data tables and 83 figures to unlock the hidden opportunities in this market: http://www.transparencymarketresearch.com/drugs-abuse-testing-market.html
North America Shows Continued Growth in Global Drugs of Abuse Testing Market
In terms of geography, North America is projected to lead the global market as it estimated to rise at a CAGR of 5.7%. The growth of the North America drugs of abuse testing market will be attributable to the ever-growing demand for testing and screening all across the U.S. High level of awareness and efforts to ensure an efficient and safe working place is expected to keep the demand for these screening across the U.S. steady during the forecast period. Out of the various end users, the diagnostic laboratories are projected to lead with a CAGR of 5.3% between 2016 and 2024.
High Prevalence of Drug Abuse Augurs Well for Overall Market
The unfortunate and illicit consumption of drugs across the world has been the primary growth driver for the global drugs of abuse testing market. Rising incidences of substance abuse and its negative impact on the lives of abusers as well as those around them have forced governments and several non-profit organizations to take a stern stand against these harmful activities. Owing to this very reason, several hospitals, offices, diagnostic laboratories, and forensic laboratories are adopting various ways of testing for drug abuse. On-the-spot testing is also gaining traction in order to ensure random checks to reduce the incidence of mishaps due to abuse.
Presence of several clinical laboratories across the globe is yet another reason fueling the demand for drugs of abuse testing products. Growing number of hospitals that depend on laboratories are expected to boost the demand for products such as sample collection devices and analyzers. Furthermore, stringent norms at workplaces to ensure employees are not involved in drugs is expected to augment the demand for work place screening in the coming years. The skyrocketing number of deaths due to rising incidence of abuse of prescription drugs is estimated to drive the market as well.
Request a sample of this report to know what opportunities will emerge in the rapidly evolving drugs of abuse testing market during 2016 - 2024: http://www.transparencymarketresearch.com/drugs-abuse-testing-market.html
Low Rate of Awareness in Developing Economies to Hamper Market
Though the global market has robust growth drivers, it is being tugged in the opposite direction by the lowering reimbursement rates. Poor reimbursement policies are likely to have a negative impact on the growth of the global drugs of abuse testing market. The market is also being restrained by the low rate of awareness in emerging economies of Asia Pacific, Latin America, and Africa. The high poverty and rampant abuse of drugs in these regions is anticipated to act as an impediment for overall market during the forecast period.
This review is based on Transparency Market Research’s research report, titled “Drugs of Abuse Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024.”

Friday, 2 September 2016

Drugs of Abuse Testing Market: Applications and Global Markets

Transparency Market Research has announced the publication of a new research report that discusses the various trends and dynamics governing the global drugs of abuse testing market. The research report, titled “Drugs of Abuse Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2018,” includes Porter’s five forces analysis to try to understand the threat of new entrants, the threat of substitute products or services, the bargaining power of suppliers, the intensity of competitive rivalry, and the bargaining power of customers. The report tries to ascertain the efforts taken by non-governmental organizations and government bodies to increase awareness about drug abuse amongst various socio-economic classes. The report also includes SWOT analysis to determine the strengths, weaknesses, opportunities, and threats influencing the segments of the global drugs of abuse testing market.
According to the research report, the global drugs of abuse testing market is expected to rise at a moderate CAGR of 4.8% during the 2013-2018 period. The growth of the global drugs of abuse testing market will be attributable to the socioeconomic losses due to the use of illegal drugs across the globe. Furthermore, the sincere efforts taken by several governments to minimize the use of these drugs and to help those abusing it will also propel the overall market. The increasing production and consumption of illicit drugs has been pinpointed as the primary cause of drug abuse by researchers. To counter these dangerous habits and illicit trade, several nations are now adopting strict drugs of abuse testing methods, thereby augmenting the global drugs of abuse testing market. The only restraint faced by this market is the unfortunate stigma associated with the testing of illicit drugs.
The global drugs of abuse testing market is segmented on the basis of technology, location, sample, and geography. The technologies used in this market are immunoassay and chromatography. Depending on location, this market is segmented into laboratory drug tests and on-site screening tests. Samples of drugs are collected through urine, hair, saliva, and others. Geographically, this market is segmented into Europe, North America, Asia Pacific, and Rest of the World.
The drugs of abuse testing market has a strong foothold in North America and Europe, as countries in these regions are keen on promoting drug screening tests, including pre-employment screening, abstinence monitoring, random drug or alcohol screening, and post-incident screening at various levels. Furthermore, government initiatives in countries such as Australia and Japan for drugs of abuse testing will also drive the overall market in the coming years.
Some of the important players in the global drugs of abuse testing market are Thermo Fisher Scientific, Psychemedics Corporation, LabCorp (Laboratory Corporation of America), Abbott Laboratories, Roche Diagnostics, Alere, Sonic Healthcare, Randox Laboratories, Quest Diagnostic, and Bio-Rad Laboratories. The research report provides a comprehensive outlook of the overall market and also explains the competitive landscape of the global drugs of abuse testing market. It also provides accurate and exact information pertaining to the regulatory framework governing the overall market. The management styles, research and development activities, product portfolio, joint ventures, strategic mergers and acquisitions, and investment outlook of these companies have been studied in this market research report.